Union Korea Pharm Co., Ltd. (KOSDAQ:A080720) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares. The program is aimed at stock price stability and shareholder value enhancement.

The program will expire on January 13, 2022. As of October 12, 2021, the company had 200,000 shares in treasury within scope available for dividend and had no shares in treasury through other repurchases.